Status:

COMPLETED

Treatment for Comorbid Social Anxiety and Alcohol Use Disorders.

Lead Sponsor:

University of California, Los Angeles

Collaborating Sponsors:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Matrix Institute on Addictions

Conditions:

Alcohol Use Disorder

Social Anxiety Disorder

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Alcohol use disorders (AUD) and social anxiety disorder (SAD) are highly comorbid and associated with significant impairment. Social anxiety comorbidity is associated with poorer addiction treatment e...

Detailed Description

In this study, potential participants will be screened either by University of California, Los Angeles (UCLA) staff or at the Matrix Institute on Addiction to determine whether they may have social an...

Eligibility Criteria

Inclusion

  • Participants must be currently enrolled in the IOP at Matrix Institute (our community partner) for the treatment of their alcohol use disorder;
  • fluent in English;
  • meet the DSM-5 criteria for social anxiety disorder and alcohol use disorder

Exclusion

  • marked cognitive impairment
  • moderate to severe suicidality
  • unstable manic or psychotic symptoms.

Key Trial Info

Start Date :

March 15 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 30 2021

Estimated Enrollment :

56 Patients enrolled

Trial Details

Trial ID

NCT03428490

Start Date

March 15 2018

End Date

April 30 2021

Last Update

November 1 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Matrix Institute on Addictions

Los Angeles, California, United States, 90025